ArticleCureus2025
Neonatal Erythroderma: Diagnostic Challenges and the Limitations of Genetic Testing.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neonatal erythroderma (NE) is an uncommon but serious presentation characterised by generalised erythema and scaling from birth. Its aetiology is diverse, encompassing congenital ichthyoses, infections, metabolic disorders, immunodeficiencies, and syndromic causes. We report the case of a full-term male neonate presenting shortly after birth with diffuse erythema, fine scaling, and areas of skin peeling, without mucosal involvement or systemic instability. Investigations, including biochemical studies, infection screening, and a next-generation sequencing ichthyosis panel, were unremarkable. Dermatology review favoured a diagnosis of congenital ichthyosiform erythroderma (CIE), and supportive management was initiated with regular emollients. The infant remained stable and was discharged with close multidisciplinary follow-up. Although the presentation was consistent with CIE, the clinical diagnosis remained uncertain at this stage. This case illustrates the diagnostic uncertainty inherent in NE and highlights the limitations of genetic testing in the neonatal period. Safe management centres on a structured multidisciplinary approach, longitudinal clinical assessment, parental education, and ongoing research to guide prognosis and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.